Intercept sets IPO range

Intercept Pharmaceuticals Inc. (New York, N.Y.) amended its IPO and now plans to sell 4.3 million shares at $13-$15 per share. A $14 price would raise $60.2 million and value the company at $210.5 million. On Sept. 4, the company filed to raise up to $75 million. BofA Merrill Lynch; BMO Capital Markets; Needham; Wedbush; and ThinkEquity are underwriters. ...